Better Oligonucleotide Production 
Starts With 
Better Equipment

Download Your Brochure 

What You’ll Get from This Brochure

Built for You

Our state-of-the-art, solid phase oligonucleotide synthesizer platform offers millimole to mole scale synthesis in a groundbreaking design that can be configured and optimized for your specific process and manufacturing facility.

The increasing number of antisense oligonucleotides and RNAi-based drugs entering Phase II or Phase III clinical trials is accelerating demand for rapid, economical process scale-up

Asahi Kasei Bioprocess helps process engineers quickly improve throughput, efficiency, and costs with Oligosynthesizers, Synthesis Columns, and Cleavage and Deprotection Systems built for your specific process and facility.

Download our brochure to explore our complete suite of solid and liquid handling systems for large-scale oligo production.

Explore our industry-leading portfolio of equipment and learn how we help manufacturers meet growing demand for oligo drug substance with high-performance columns, systems, and automation solutions.

  • In-depth overviews for every Asahi Kasei Bioprocess oligosynthesis product

  • Key features & options to better meet your needs

  • Detailed breakdowns of how each system adds value to synthesis, cleavage and deprotection, purification, and concentration

  • Guidance on enhancing everything from safety and efficiency to throughput and costs

  • A quick walkthrough of our system control platform, OCELOT(™), including screenshots and capabilities

Here’s what’s inside:

Get Your Brochure

Scale Oligo Production Your Way

Asahi Kasei Bioprocess America, Inc

1855 Elmdale Ave., Glenview, IL 60026, USA

The Most Experienced Partner for Oligonucleotide Manufacturing 

Asahi Kasei Bioprocess is trusted by the world’s leading manufacturers to produce preclinical, clinical, and validation batches of oligo drug substance. With 15 years of experience in oligonucleotide fluid management, we understand that oligonucleotides are a rather unique breed of therapeutic — chemically synthesized, yet much larger in size than classic small molecules.

Hybrid Design

Our engineers employ a hybrid approach when designing large-scale equipment, blending the best of antibody and small molecule equipment design principles to generate the ideal solution for your oligonucleotide.

Trusted Outcomes

Our reliable, cutting-edge bioprocess equipment, consumables, and scientific support services help manufacturers of regulated therapeutics safely and efficiently produce medicines that patients can trust.

Ready to start improving batch production? Download our brochure and tell us about your specific process and manufacturing needs.